SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-24-047931
Filing Date
2024-04-25
Accepted
2024-04-25 08:03:55
Documents
2
Period of Report
2024-04-25

Document Format Files

Seq Description Document Type Size
1 6-K 6-k_escmid_product_launc.htm 6-K 24357
2 EX-99.1 vrax-ex99_1.htm EX-99.1 19250
  Complete submission text file 0000950170-24-047931.txt   44820
Mailing Address BIOCITY GLASGOW BO'NESS ROAD, NEWHOUSE LANARKSHIRE X0 ML1 5UH
Business Address BIOCITY GLASGOW BO'NESS ROAD, NEWHOUSE LANARKSHIRE X0 ML1 5UH 44 020 7788 7414
Virax Biolabs Group Ltd (Filer) CIK: 0001885827 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-41440 | Film No.: 24873074
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)